Prihlásiť sa Zaregistrujte sa zadarmo

Dlh / vlastný kapitál spoločnosti Adaptimmune Therapeutics Plc

Aká je hodnota metriky Dlh / vlastný kapitál spoločnosti Adaptimmune Therapeutics Plc?

Hodnota metriky Dlh / vlastný kapitál spoločnosti Adaptimmune Therapeutics Plc je 6.15

Aká je definícia metriky Dlh / vlastný kapitál?



Dlh / vlastný kapitál (Debt to equity ratio) ukazovateľ vyjadruje pomer vlastného kapitálu a cudzích zdrojov na financovanie majetku spoločnosti.

The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.

Dlh / vlastný kapitál spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Adaptimmune Therapeutics Plc

Čomu sa venuje spoločnosť Adaptimmune Therapeutics Plc?

adaptimmune llc is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary t-cell receptor platform that has the potential to transform the treatment of cancer. established in 2008, the company has grown from being privately held to one of the most successful biopharmaceutical initial public offerings (ipo) in 2015. with u.s. operations based in philadelphia, pa, adaptimmune is a company founded on strong science that has led to a robust pipeline of immuno-oncology product candidates, a growing research & development platform and ongoing plans for expansion. for more information about adaptimmune, please visit www.adaptimmune.com. if interested in joining our fast growing team, click on the careers tab of this page.

Firmy s metrikou dlh / vlastný kapitál podobnou spoločnosti Adaptimmune Therapeutics Plc